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(i) 
ABSTRACT 
The effect of adrenalectomy and corticosteroid administration on 
precursor uptake and RNA synthesis in rat kidney was studied. A number 
of radioactively labeled precursors (3H-uridine, 3H-cytidine, and 
14
c-orotic acid) were used to determine the time course of incorporation 
into "the acid soluble pool and the alkaline hydrolyzate fractions of 
both the normal and adrenalectomized rats. The incorporation of these 
precursors into both RNA and acid soluble pool was linear for at least 
20 minutes. 
A general decrease in the rate of incorporation of 3H-cytidine and 
14
c-orotic acid into the alkaline hydrolyzate fraction of kidneys was 
observed 7 to 8 days after adrenalectomy as compared to normal animals. 
Administration of a single dose of aldosterone 1 or 2 hours prior to the 
isotope, increased the rate of incorporation into acid soluble pool as 
well as into the alkaline hydrolyzate fraction to a level greater than 
that in normal rats. Actinomycin D administration 2 hours prior to the 
14 C-arotic acid markedly decreased RNA synthesis,but had no significant 
effect on the uptake of precursor into the acid soluble pool. Actinomycin 
D plus aldosterone treatment, compared to actinomycin D alone, resulted 
in an increase in precursor uptake into the acid soluble pool. 
These studies suggest that most of the stimulatory effect of 
aldosterone on the incorporation of exogenous precursor into RNA of rat 
kidney is attributable to an increase in the rate of precursor uptake. 
There may also be a genuine stimulation of RNA synthesis as aldosterone 
increases the RNA:DNA ratio of adrenalectomized rat kidneys to the levels 
(ii) 
of normal animals. 
The effects of single injections of deoxycorticosterone, corti-
costerone and cortisol on the incorporation of14c-orotic acid into the 
kidneys of adrenalectomized rats were also studied. Deoxycorticosterone, 
corticosterone stimulated the precursor incorporation into acid soluble 
pool but no effect was observed on the incorporation into the alkaline 
hydrolyzate fraction. On the other hand, cortisol administration 
caused a decrease in the incorporation of precursor into the alkaline 
hydrolyzate fraction without affecting precursor incorporation into the 
acid soluble pool, suggesting that it may decrease RNA synthesis in the 
kidneys of adrenalectomized rats. 
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(iv) 
ABBREVIATIONS 
ACTH - adrenocorticotropic hormone 
DNA - deoxyribonucleic acid 
RNA - ribonucleic acid 
m-RNA - messenger ribonucleic acid 
r-RNA - ribosomal ribonucleic acid 
TCA-cycle - tricarboxylic acid cycle 
HMP-shunt - hexose monophosphate shunt 
c-AMP -adenosine 3',5'-cyclic monophosphate 
Na-K-ATPase - sodium, potassium activated adenosine triphosphatase 
dpm - disintegrations per minute 
cpm - counts per minute 
TCA - trichloroacetic acid 
Tris - tris (hydroxymethyl)amino methane 
o.n. - optical density 
~X 
- adrenalectomized 
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•••••••••• Our own wronged flesh 
May work undisturbed, restoring 
Th~ order we try to destroy, the r~ythm 
We spoil out of spite: valves close 
And open exactly, glands secrete, 
Vessels contract and expand 
At the right moment, essential fluids 
Flow to renew exhausted cells, 
Not knowing quite what has happened ••••••• 11 
-- Nones, W. H. Auden (1) 
INTRODUCTION 
Most of the cellular processes which ultimately lead to a variety of 
secondary manifestations such as growth, differentiation or development 
are initiated or regulated by hormones (2). Hormones have been defined 
by many workers (3-8) as chemical substances, secreted in trace amount by 
specific cells, and transported in the blood circulation to the organs on 
which their effect is produced without contributing significant amounts 
- 1 -
of energy or matter to the tissues. Some hormones exert relatively specific 
effects for ·specific target cells; other hormones are more general in 
both action and target. 
Hormones are commonly divided into three classes according to their 
structure, irrespective of their physiological or biochemical functions: 
- 2 -
(i) amino acid derivative hormones, for example, epinephrine and thyroxine, 
(ii) a larger group of steroid hormones. for example, the corticosteroids 
of the adrenal cortex and the estrogens and androgens of the ovaries and 
testes, and (iii) the largest group of peptide and protein hormones of 
which adrenocorticotropic hormone (ACTH) and insulin are examples. 
A. GENERAL MECHANISM OF HORMONE ACTION: 
It has been shown that hormones exert a regulatory function over the 
biosynthesis of protein(s) in their respective target organs although the 
exact mechanism by which they operate is unknown. RNA synthesis has been 
implicated in the mechanism of action of many hormones; for example, in 
the action of cortisol on liver (9), cortisone on liver (10), growth 
hormone on liver (11), testosterone on seminal vesicle (12), ACTH on the 
adrenal (13) and estrogen on the uterus (14). These observations suggest 
a hypothetical mechanism, based upon the repressor-inducer model of 
bacteria (15), by which hormone action is expressed through selective 
control of m-RNA synthesis (16). Tata (17), however, has reported many 
observations which are inconsistent with this being the only mechanism of 
hormone action. Therefore, several theories concerning the mechanism of 
hormone action have been proposed. 
B. HORMONE ACTION AT THE NON-TRANSCRIPTIONAL LEVEL: 
(i) Control- at ceU permeabil-ity 
Some hormones such as insulin (18) and ACTH (19) appear to control 
- 3 -
protein synthesis at the translational level, by increasing the metabolic 
rate rather than having a direct effect on RNA synthesis. Many other 
reports that insulin acts at the cell membrane and is involved in membrane 
transport are consistent with a non-transcriptional role for insulin 
action (20, 21). Sharp and Leaf (22) suggested that the primary action 
of aldosterone is on the cell membrane, stimulating the synthesis of 
protein which acts like a permease in facilitating entry of sodium through 
the mucosal surface of the tissue. 
Means and Hamilton (23, 24) observed an increased 3H-uridine uptake 
in the presence of estrogen as well as increased RNA synthesis in rat 
uterus following injection of estrogen. Agarwal et aZ (25) measured an 
increase in precursor uptake in the acid soluble pool of rat liver after 
cortisone treatment. A similar increase in RNA precursor uptake has also 
been reported by many other workers (26-28). Miller and Baggett (29) 
concluded that estrogen primarily increases the incorporation of nucleosides 
into nucleotide pools in mouse uterus. Billing et aZ (30) were unable to 
show any increased RNA synthesis by the immature rat uterus until at least 
5 hours after administration of estradiol when corrections were made for 
increased uptake of RNA precursors. It appears from these studies that 
one of the mechanisms of hormone action is to increase metabolite concen-
tration by increasing transport across the cell membrane. 
(ii) Post-transa~iptionaZ ControZ 
Tomkins et aZ (31) proposed a "translational repressor" mechanism to 
explain the superinducibility by actinomycin D of dexamethasone-induced 
tyrosine transaminase. A marked increase in enzyme activity was .observed 
following dexamethasone administration to hepatoma cell cultures, with-
out detecting any increase in total cellular RNA or its rate of synthesis 
from labeled precursors (32). Reel and Kenney(33) reported that the 
superinduction resulted from inhibition of transaminase degradation by 
actinomycin D rather than an increased rate of synthesis. Thus it is 
still unclear and controversial whether . translation repressors exist, and 
what their nature might be. 
Studies of cellular ultrastructural changes reveal another possible 
category of translational control. Palmiter et aZ (34), using physical 
and electron microscopic techniques studied the organization of ribo-
somes into polysomes in the chick oviduct when either estrogen or pro-
gesterone was administered. An early assembly of polysomes was observed 
from preexisting ribosomes before new ribosomes entered the cytoplasm. 
These authors related the increased rate of protein synthesis during 
stimulation with an organization of ribosomes into polysomes. This . 
observation is similar to the prolactin induced polysome assembly in 
- 4 -
rabbit mammary tissue (35) and ultrastructural changes of differentiating 
explants in response to hormones (36). Henshaw et aZ (37) have proposed 
that membrane bound ribosomes are more active than free ribosomes, which 
might be a meChanism to control rates and types of protein synthesized (38). 
Another type of post-transcriptional control has been shown to involve 
RNA transport from the nucleus to the cytoplasm. Spirin (39) suggested 
that m-RNA may transfer from the nucleus to the cytoplasm as nucleoprotein 
complex {or informosomes) which provides a potential translational control 
point. 
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C. HORMONE ACTION AT THE TRANSCRIPTIONAL LEVEL: 
The most often observed result of hormone administration is a marked 
increase in RNA synthesis. There is still controversy over which type of 
RNA is synthesized during hormone action. Some investigators argue for 
hormone action through selective stimulation of new m-RNA (16, 40), while 
Tata (17) views hormone action as resulting from the synthesis of all typesof 
RNA an especially new highly active ribosomes. This latter view of hormone 
action has now been more widely accepted. Jackson and Sells (41) observed 
no increase in m-RNA without similar increase in all classes of RNA. 
They suggested m-RNA and r-RNA increase in a parallel manner. A similar 
increase in all classes of RNA has also been reported after cortisol (42) 
and aldosterone (43) administration. Enhanced synthesis of ribosomal RNA 
has also been reported with the administration of estrogen, testo~terone, 
growth hormone and thyroid hormones (44). 
On the other hand considerable evidence has been reported regarding 
selective m-RNA synthesis in response to hormone action (40, 45, 46). These 
investigators consider that RNA which is rapidly labeled (40),extracted by 
hot detergent phonol (42), or high pH (46),and which is similar to DNA in 
composition and able to stimulate amino acid incorporation in a cell free 
32 
system (47) to be m-RNA. Hydrocortisone stimulates Po4 incorporation into 
the hot phenol extracted RNA (46) and 3H-orotic acid incorporation into the 
high pH extracted RNA (45). 
O'Malley and McGuire (48), using RNA-DNA hybridization, were able to 
show new RNA species in the chick oviduct 6 hours after progesterone 
administration and before ovidin synthesis. The evidence in support of 
new m-RNA synthesis does not exclude additional effects on ribosome 
synthesis. 
D. EFFECT OF ADRENAL INSUFFICIENCY: 
Adrenal glands are vital to the maintenance of life in many living 
organisms. Bilateral removal of these glands r~sults in profound physio-
logical and biochemical changes (49-51). A variety of symptoms such as 
loss of appetite, muscle weakness, polyuria, low blood pressure, diarrhea, 
and hypoglycemia appears within a few days,depending on species. One of 
the most important effects of adrenal insufficiency is the failure of the 
kidneys to retain sodiUm and excrete potassium (52-55) • . As a result, the 
plasma level of potassium rises and the sodium level falls (56-60). 
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Unless the effects are reversed, death occurs within a few days to 
several weeks depending on species. The life of an adrenalectomized animal 
can be prolonged by supplying 1% sodi~ chloride in the drinking water or 
by ·administering adrenal hormones. Both of these treatments appear to 
reverse all the aforementioned effects. 
The steroid hormones secreted by the adrenal gland may be divided 
into two classes: Glucocorticoids and mineralocorticoids. The most common 
glucocorticoids .found are cortisol (man and dog) and corticosterone (man, 
dog and rat) (61-63). The most potent mineralocorticoid in man, dog, and 
rat is aldosterone (64-66). 
These hormones also show some ·overlap in their activity; for example, 
cortisol and corticosterone have been shown to exert mineralocorticoid 
- 7 -
activity whereas aldosterone shows some glucocorticoid activity . (67). 
E. ADB~OOORTICOSTEROIDS .AND LYMPHOID TISSUES: 
Adrenocorticosteroids have also been shown to cause involution of 
lymphoid tissues (68-69). Thymic involution in the rat was reported after 
the administration of both steroid and non-steroid hormones -(70) and 
Mendelson and Finland (71) reported a marked decrease in the average 
weight of the spleen in cortisol treated mice as compared to the contJiol 
animals. 
These hormones have also been shown to inhibit DNA and RNA synthesis 
in lymphoid tissue. Knutson and Lundin (72) reported a significant de-
crease in the incorporation of tritiated thymidine into DNA of the thymus 
and spleen followi_ng cortisone treatment. A prolonged treatment of mice 
with cortisol or ACTH results in a decreased incorporation of labeled 
nucleotides into nucleic ac.ids of the lymph nodes, thymus and spleen · (73). 
Similarly, in the rat DNA synthesis in these tissues decreases following 
cortisol injection (74). RNA synthesis in isolated rabbit lymph nodes (75) 
and in rat thymocytes (76) is also rapidly inhibited following the admin-
istration of cortisol. 
F. EFFECT OF ALDOSTERONE-PROPOSED MECHANISM OF ACTION: 
The effect of aldosterone on sodium transport has been established 
in kidney and intestine (77, 78), sweat glands (79, 80), salivary glands 
(81), and anuran epithelia such as toad bladder (82). In addition, 
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aldosterone has also been shown to alter the electrolyte movement in human 
erythrocytes (83), in rat brain (84), and in human laryngeal carcinoma 
cells (85) cultured in vitro • 
(i) Effeat on isolated toad bladder 
In 1961 Crabbe (86) observed an effect of aldosterone on sodium 
transport in isolated toad bladder. A latent period of about 60 to 90 
minutes preceded the effect on sodium transport (87), and the duration 
of this latentperiod could not be reduced by increasing the concentration 
of aldosterone (86). This latent period coincides with a proposed early 
increase in RNA and protein synthesis following the accumulation of tri-
tiated aldosterone in toad bladder nuclei (88-91). Rousseau and Crabbe (92) 
observed stimulation of a rapidly labeled RNA fraction following admin-
istration of aldosterone. Pretreatment of toad bladder with actinomycin 
D or puromycin decreased the effect of aldosterone on sodium transport 
(88, 89). The inhibitory action of actinomycin D was oaly observed if 
the tissue was exposed· to inhibitor prior to the administration of aldosterone 
(93), suggesting that RNA and protein synthesis must precede the effect 
of aldosterone on sodium transport and are not secondary to intracellular 
sodium concentration changes (94). 
Recently Rousseau and Crabbe (95) showed an increase in . total nuclear 
RNA synthesis and 3H-uridine uptake of toad bladder after aldosterone ad-
ministration but no effect was obserVed on cytoplasmic RNA turnover rate. 
m-RlfA';synthesis and on the pattern of protein synthesis. Sharp and 
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Komack (96) could not detect any stimulation of RNA metabolism unless a 
concentration of aldosterone 100-fold greater than that required to 
stimulate sodium transport was used. These studies suggest that the 
proposal that the effect of aldosterone on sodium transport is mediated via 
RNA and protein synthesis in toad bladder remains on indirect evidences. 
In the toad bladder, the stimulation of sodium transport by aldosterone 
has also ~een shown to depend upon the availability of specific metabolic 
substrates (97, 98). Pyruvate, or compounds which yield pyruvate, enhance 
sodium transport in the presence of aldosterone whereas acetate and other 
tricarboxylic acid cycle (TCA-cycle) intermediates fail to stimulate this 
effect. The significance of the effect of various substrates on aldosterone 
enhanced sodium transport is not yet clear. Kirsten et aZ (99) have shown 
that the activities of the TCA-cycle enzymesare increased following the 
addition of aldosterone. The increases in the level of these enzyme 
activities was correlated with the increase in sodium transport. 
Recently Kirchberger et aZ (98, 100) showed a correlation between the 
effect of aldosterone on sodium transport and the decrease in evolution of 
14 14 * co2 from 1- C-glucose in toad bladder. The decrease in evolution of 
14
co2 persists even in the absence of sodium and has characteristics 
similar to those of sodium transport with regard to the time of onset, 
concentration response, steroid specificity and sensitivity to 
* Due to the combined al~ion of the Embden-Meyerhof paf~way and the 
tricarboxylic acid cycle, co2 from l-14c-glucose and 6- C-glucose is 
released at equal initial iates, whereas the HMP shunt pathway initially 
yields 14co2 only from 1-l C-glucose. 
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actinomycin D and spirolactone. It was suggested that the stimulation of 
sodium transport and the inhibition of the hexose monophosphate shunt (HMP 
shunt) pathway appears to be an effect of mineralocorticoids. In addition, 
. 14 14 these effects of aldosterone to decrease the evolut1on of co2 from 1- C-
glucose and to stimulate sodium transport have been shown to be reproduced 
by adenosine 3',5'-cyclic monophosphate (c-AMP) (101). It was suggested 
that c-AMP might mediate the action of aldosterone, although the authors 
were not able to detect any change in the tissue concentration of c-AMP 
even after prolonged incubation with the hormone. 
Hill et aZ (102) found no effect of aldosterone on the Na-K-ATPase 
activity of toad bladder, confirming earlier reports of Sharp and Leaf (97) 
and Banting and Canady (103). The authors suggested that aldosterone induced 
stimulation of sodium transport in toad bladder does not appear to involve 
a change in the activity of Na-K-ATPase, nor its dependence on sodium. 
(ii) Effeat on kidney.' 
The effects of aldosterone on renal function are also well known 
(104-107), to increase the removal of sodium from and addition of potassium 
to the glomerular filtrate, presumably by affecting active transport or 
exchange of these ions. Aldosterone has been shown to increase the 
sodium resorption at the distal tubule of the nephron (108, 109). There is 
also a lag period of 30 to 90 minutes before an effect of aldosterone on 
sodium resorption is observed (104). It has been suggested that the 
action of aldosterone is preceded by a stimulation in the synthesis 
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of RNA and protein (110-112). Williamson et aZ reported that actinomycin 
D significantly inhibits the antinatrluretic action of aldosterone (113). 
However, it has also been shown that actinomycin D did not inhibit the 
kaliuretic response to aldosterone despite the similarity in the time 
course of the effect on sodium and potassium excretion (112, 113). A 
number of reports have appeared on the effect of aldosterone on renal RNA 
synthesis (110, 111). The incorporation of precursors into RNA is 
enhanced by aldosterone before the effect on urinary sodium is achieved. 
Moreover, the enhancement is inhibited by actinomycin D. Forte and Landon 
(43) observed an increase in the synthesis of all species of renal RNA. It 
is still not clear how aldosterone produces a specific effect if all species 
of RNA are stimulated. Recently Congote and Trachewsky (114) using RNA-DNA 
hybridization technique demonstrated a qualitative change in nuclear RNA of 
rat kidney cortex after aldosterone administration. They observed a specific 
increase i~ the hybridization activity of nuclear RNA with repetitive DNA. 
(115) 
Liu et at/observed a decrease in the specific activities of some 
mitochondrial enzyme of rat kidney after adrenalectomy which can be restored 
by aldosterone treatment. :'Similar results have been reported by Kinne and 
Kirsten (116). These findings are similar to the reported increase in the 
activity of TCA-cycle enzymes in toad bladder after aldosterone administrat-
ion (99), and also support Edelman's view that aldosterone acts via a 
metabolic pathway (88). 
J~rgensen (117) has related the reduction in Na-K~ATPase activity to 
the rate of change in sodium and potassium concentration in plasma during 
developing adrenal insufficiency. He reported that a high sodium 
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intake can prevent the reduction of enzymatic activity and suggested that 
Na-K-ATPase is partly influenced by the sodium concentration in plasma. 
Kartz and Epstein (118, 119) observed an increase in Na-K-ATPase 
activity when sodium resorption was increased after feeding rats with 
high protein diet and that Na-K-ATPase activity was reduced~en sodium 
transport was diminished following bilateral adrenalectomy. Chignell and 
Titus (120) showed a decrease in the activity of Na-K-ATPase after adrenal-
ectomy. These authors observed no change in enzyme activity after 3 hours 
of aldosterone treatment. Landon et aZ (121) reported a decrease in Na-K-
ATPase activity in dialyzed kidney membrane of adrenalectomized and normal 
rats treated with aldactone. The enzyme activity was restored to normal 
level in adrenalectomized rats treated with a high concentration of aldo-
sterone. J~rgensen (122) observed that the repeated injection of aldosterone 
increases the activity of Na-K-ATPase in the microsomal fraction from whole 
kidney. These results are consistent with an increase in resorption of 
sodium following repeated injection of aldosterone to adrenalectomized rats. 
These results in rat kidneys are inconsistent with the reported findings 
in toad bladder, where no effect on the activity of Na-K-ATPase was observed 
after aldosterone administration (97, 102, 103). 
Recently Knox and Sen (123), using double label technique, reported 
an increase in Na-K-ATPase protein. They suggested that Na-K-ATPase may 
be one of the aldosterone induced proteins required for enhanced active 
sodium transport. These results are consistent with the hypothesis that 
aldosterone prcduces the antinatr.hretic action via protein synthesis. 
STATEMENT OF PROBLEM 
It is apparent from the introductory discussion that the kidneys of 
adrenalectomized rats are deficient in sodium retention. This function 
can be largely restored by the injection of aldosterone and to a smaller 
extent by other adrenocorticosteroids. The action of aldosterone appears 
to be mediated via RNA and protein synthesis as it can be blocked by act-
inomycin D and puromycin. Previous workers (43, 111, 112) have also 
shown that aldosterone stimulates the incorporation of radioactive pre-
cursors into RNA and this has been interpreted as meaning that RNA syn-
thesis is stimulated. However, it has become increasingly clear that 
hormones can modify pool sizes (124) and the rates of precursor uptake 
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(26, 27, 29, 125); consequently, the rate of incorporation of exogenous 
precursors is not necessarily a valid measure of the rate of RNA synthesis. 
We, therefore, examined the effect of adrenalectomy and of adrenocorti-
costeroids treatment on precursor uptake and acid soluble pool as well 
as its effect on the incorporation of precursor into acid insoluble 
material in an attempt to decide how much of the apparent effect is due 
to the pool size and uptake effects and how much represents a genuine 
stimulation of RNA synthesis. 
MATERIALS AND METHODS 
ANIMALS: 
Male Sprague-Dawley rats, weighing 100 to 150 gms were used in these 
experiments unless otherwise indicated. Animals were obtained from the 
Medical School, Memorial University of Newfoundland; St. John's, New-
foundland, or f1.·om the Canadian Breeding Laboratories, St. Constant, 
Quebec. Bilateral adrenalectomy was performed by the dorsal route and 
adrenalectomized animals were maintained on 1% sodium chloride and Purina 
Laboratory Chow ad libitum. Adrenalectomized rats were used 7 to 8 days 
after being operated upon unless otherwise indicated. 
CHEMICALS: 
All hormones used in this work, with the exception of aldosterone, 
were obtained from Sigma Chemical Co., St. Louis, Mo. Aldosterone was 
obtained from E. M. Reagent Div., Brinkmann Instruments Inc., Westbury, 
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N. Y •. Protosol (Tissue solubilizer) and Aquasol (Liquid scintillation 
counting cocktail) were purchased from New England Nuclear, Boston, Mass. 
Bio-solv. solubilizer BBS2 and BBS3 were obtained from Beckman Instruments 
Inc., Fullerton, California. Actinomycin D (from Streptomyces chrysomallus) 
was obtained from Sigma Chemical Co., St. Louis, Mo. All other chemicals, 
unless otherwise indicated were obtained from J. T. Baker Chemical Co., 
Phillipsburg, N. J., or Sigma Chemical Co., St. Louis Mo. All chemicals 
were of the analytical grade purity. 
5-3H-Uridine, specific activity 25.4 curies per millimole and 3H-water, 
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specific activity 1 millicurie per gram were purchased from New England 
Nuclear, Boston, Mass. 5-3H-Cytidine, specific activity 1 curie per milli-
mole, 6-14c-Orotic acid, specific activity 60.8 millicurie per millimole 
and 1~-Toluene, activity 7.15 x 105 dpm per gram were purchased from 
Amersham/Searle, Arlington Heights, Illinois. 
PREPARATION OF SOLUTIONS: 
(i) Buffer--
Tris/KCl- MgC12 buffer, pH 7.4 
0.04 M Tris, 0.1 M KC.l, 0.004 M MgC12 , adjusted to pH 7.4 with con-
centrated HCl. 
(ii) Hormones---
Aldosterone and deoxycorticosterOne were prepared in a small amount 
of 95% ethanol and were diluted with 0.9% saline to appropriate concen-
trations. 
Cortisol and corticosterone were prepared in 0.9% saline and were 
used as saline suspensions. 
· USE OF DIFFERENT LABELED PRECURSORS IN TIME COURSE STUDIES: 
In these studies animals were divided into two groups: normal and 
adrenalectomized. In one series of experiments, each animal received an 
intraperitoneal injection of 3H-uridine (25 ~Ci/100 g body weight) 5, 10, 
20, 30, 40, or 75 minutes before sacrifice. In another series, each 
animal received an intraperitoneal injection of 3H-Cytidine (25 ~Ci/100 g 
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body weight) or 14c-orotic acid (5 ~Ci/100 g body weight) 5, 10, 20, 40 
or 75 minutes before sacrifice. 
STUDIES WITH HORMONES: 
In these experiments, animals were divided into three groups: normal, 
adrenalectomized and adrenalectomized plus hormone treated. The animals 
were injected intraperitoneally with either hormone or with saline 1 or 2 
hours prior to the tracer injection. The following doses of hormones were 
used: aldosterone (5 ~g/100 g body weight), deoxycorticosterone (100 ~g/100 g 
body weight), cortisol (2 mg/100 g body weight), corticosterone (2 mg/100 g 
body weight). 
In one series of experiments each animal received an intraperitoneal 
3 injection of H-cytidine (25 ~Ci/100 g body weight) 20 minutes before 
sacrifice. 
In another series each animal received an intraperitoneal injection of 
14 C-arotic acid (5 ~Ci/100 g body weight) 20 minutes before sacrifice. 
The 20 minutes time for isotope incorporation in these experiments was 
taken on the basis of time course studies. It was observed that the incor-
poration of 3H-cytidine and 14c-orotic acid into both RNA and the acid 
soluble pool was linear for 20 minutes but not beyond this time. 
STUDIES WITH ACTINOMYCIN D AND ALDOSTERONE: 
In these experiments, adrenalectomized rats were injected intraperiton-
eally with 0.9% saline, aldosterone (5 ~/100 g body weight), actinomycin D 
(50 ~/100 g body weight) or actinomycin D (50 ~g/100 g body weight) plus 
aldoster.one (5 ~/100 body weight) 2 hours prior to the isotope injection. 
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14 All animals received intraperitoneal injection of C-~rotic acid (5 ~Ci/ 
100 g body weight) 20 minutes before sacrifice. 
TISSUE HOMOGENIZATION AND ISOLATION OF DIFFERENT FRACTIONS: 
To isolate the acid soluble pool and the alkaline hydrolyzate fraction 
(RNA £~action), the following procedu~e - was employed. Animals were 
sacrificed by cervical dislocation at the designated time. Kidneys were 
removed quickly and frozen in liquid nitrogen. All subsequent steps were 
carried out at 0 - 4° unless· otherwise indicated. Frozen kidneys were 
homogenized in 4 ml of Tris-KCl-MgC12 buffer, -pH 7.4 (126) in a Teflon 
glass homogenizer which was washed twice with 1.5 ml of buffer. The 
final volume of homogenate was made to 9 ml with buffer. 0.2 ml of 50% 
TCAwas added to a sample (0.8 ml) of homogenate which was then diluted 
with 3.5 ml of 5% TCA and centrifuged for 10 minutes at 2500 rpm in an 
International model HN-S centrifuge in the cold room, to give acid soluble 
and acid insoluble fractions. The acid insoluble pellet was washed twice 
with .2 m1 of 5% TCA, and the supernatants were combined to give the acid 
soluble. fraction. 
The lipids were then removed from the acid insoluble fraction by 
suspending and centrifuging in 5 ml each of ethanol, chloroform-ethanol 
(2:1) and ether . (126). The acid insoluble defatted residue was hydrolyzed 
in 2.5 m1 0.3 M KOH at 37° for 16-18 hr and then acidified with 1 ml of 
50% TCA. The soluble portion of this alkaline hydrolyzate was collected 
after centrifuging for 10 minutes at 2500 rpm. The residue was washed 
twice with 1 ml of 5% TCA, and the supernatants were combined to give 
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alkaline hydrolyzate fraction, an aliquot of which was assayed for radio-
activity and RNA content. 
The DNA was isolated from 0.1 ml of homogenate by Schneider method 
(127). The 0.1 ml homogenate was diluted with 1.9 ml of 5% TCA and heated 
for 15 minutes at 90°. The supernatant was collected after centrifugation 
and was used for DNA determination. 
DETERMINATION OF RNA AND DNA: 
An 0.5 ml aliquot of alkaline hydrolyzate was used for RNA determination. 
The RNA was determined by the orcinol method (128), using yeast RNA as standard. 
The DNA was determined in 1 ml of extracted supernatant with diphenylamine 
reagent (129), using calf thymus DNA as standard. 
MEASUREMENT OF OPTICAL DENSITY: 
Ar1 0.5 ml aliquot of acid soluble fraction was diluted to 2 ml with 5% 
TCA and optical density was measured at 260 m~ against 5% TCA in a Beckman 
DB-G spectrophotometer. 
DETERMINATION OF RADIOACTIVITY: 
Total radioactivity was measured on 0.1 ml aliquots of homogenate, solu-
o bilized with 0.4 ml of Protosol in a glass counting vial at 55 for 2 hours. 
The vials were brought to room temperature and the pH was adjusted to between 
6 and 7 with 0.02 ml concentrated HCl. Samples were counted after adding 15 
ml of Aquasol. The total radioactivity was expressed as counts per minute per 
mg of DNA. For measurements of radioactivity in the acid soluble pool and the 
alkaline hydrolyzate fraction, 0.2 ml aliquot of these fractions were counted 
in Aquasol. The results for acid soluble fraction and acid insoluble fraction 
were expressed as counts per minute per O.D. at 260 m~ and counts per 
minute per mg of DNA respectively. The calculation in each case was 
corrected for 9 ml of original homogenate. 
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All radioactive samples were counted in a liquid scintillation 
spectrophotometer (Intertechnique Model SL30). Quench corrections were 
performed by recounting the samples after addition of known amounts of 
3H-water and 14c-toluene as internal standard. Counting efficiencies and 
14 background counts were as follows: for C, 73 - 76 %, 58 - 60 cpm; 
for 3H, 26 - 28 %, 27 - 33 cpm. 
USE OF DIFFERENT CONDITIONS TO DETERMINE THE TOTAL TISSUE AND ALKALINE 
HYDROLYZATE FRACTION RADIOACTIVITY: 
Several conditions were employed to isolate the total and alkaline 
hydrolyzate fraction radioactivity. In these experiments, the animals 
received an intraperitoneal injection of 3H-uridine (25 ~Ci/100 g body 
weight) 20, 40, or 150 minutes before sacrifice. 
In one experiment, the method employed was similar to that described 
above except that the total counts were measured with or without Protosol 
treatment and 0.2 N NaOH or 0.3 M KOH was used to isolate the alkaline 
hydrolyzate fraction. 
In another experiment, a number of solubilizers were employed to 
measure the total radioactivity from an aliquot of tissue homogenate. The 
different conditions used were as follows: 
A. Use of Protosol, BBS2 , or BBS3 
0.1 ml aliquots of homogenate were solubilized with 0.4 ml of Protosol, 
BBS2 or BBS3 in a glass counting vial at 55° for 2 hours. The vials were 
brought to room temperature. The pH was adjusted to between 6 and 7 with 
concentrated HCl in the Protosol treated vials. Samples were counted after 
adding 15 ml of Aquasol. 
B. Use of Hot TCA: 
A 0.1 ml aliquot of homogenate was diluted with 0.4 ml of 20% TCA. 
The suspension was heated to 95° for 15 minutes, cooled and counted by 
adding 15 ml of Aquasol. 
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RESULTS 
VALIDITY OF METHOD USED: 
Table I shows the results obtained for the total tissue and alkaline 
hydrolyzate fraction radioactivity under different conditions. 
The use of :Protosol treatmen~to solubilize an aliquot of tissue 
homogenate for the measurement of total tissue counts appears to be nee-
essary because the total counts were less than the total of acid soluble 
pool plus alkaline hydrolyzate fraction counts when Protosol treatment 
was avoided. The recovery of total counts with Protosol treatment was 
from 97 to 102 percent (Table I). 
Table II shows the results obtained by the use of different solubil-
izer for the isolation of total tissue radioactivity. 
It is clear that the total counts obtained with BBS2, BBS3 or hot 
TCA treatment are less than the total counts obtained with Protosol treat-
ment. 
The recovery of total counts with Protosol treatment was about 97 
to 101 percent of the total acid soluble pool plus alkaline hydrolyzate 
fraction counts. There was no significant difference in efficiencies and 
in background counts by using different methods of sample preparation. 
* There is a drawback by using Protosol in that it takes at least 48 
hours to give constant counts (there might be a reaction between Protosol 
and Aquasol). However this can be overcome by adjusting the pH to be-
tween 6 and 7 with concentrated HCl before the addition of Aquasol (as 
has been mentioned in Materials and Methods. 
TABLE I 
EFFECT OF DIFFERENT CONDITIONS ON THE ISOLATION OF TOTAL TISSUE AND ALKALINE HYDROLYZATE 
FRACTION RADIOACTIVITY OF NORMAL RAT KIDNEYS 
b . 
Alkaline hydrolyzate Total acid soluble tTotal counts fraction counts 
rAcid soluble plus 
*Total recovery Animal +Protosol -Protosol ttDifference fraction NaOH KOH alkaline hydrolyzate 
Nwnber treatment treatment (%) counts treatment treatment fraction counts (%) 
A 292320 235550 -18 286791 10813 297604 102 
B 270900 200830 -26 253515 9833 263348 97 
c 301000 235550 -22 283865 12537 296402 98 
D 290290 229950 -21 271119 9011 280130 97 
All animals received an intraperitoneal injection of 3n-uridine (25 ~Ci/100 g body weight) 150 minutes before sacrifice. 
t In the case of +Protesol, 0.1 ml of homogenate was solubilized with 0.4 ml Protosol as described in Materials and Methods. 
In the case of -Protosol, samples were counted without Protosol treatment. 
a Acid soluble radioactivity is that which was not precipitated by TCA treatment. 
b Alkaline hydrolyzate radioactivity is measured by hydrolyzing the acid insoluble residue with alkali as i ndicated. 
tt Difference (%) indicates the percentage difference of counts between Protosol and no Protosol treatment. 
* Total recovery was calculated by comparing the sum of acid soluble plus alkaline hydrolyzate fraction counts with the 
total counts obtained by P.rotosol treatment of the homogenate. 
N 
N 
Table II 
EFFECT OF DIFFERENT SOLUBILIZERS ON THE MEASUREMENT OF TOTAL TISSUE aADIOACTIVITY 
otosol 
atment 
6830 
1840 
BBS2 
treatment 
678600 
466110 
Difference 
(%) 
-8 
-7 
OF NORMAL RAT KIDNEYS 
Total Counts 
BBS3 
treatment 
595260 
416250 
Difference 
(%) 
-19 
-17 
Hot TCA 
treatment 
671310 
430380 
Difference 
(%) 
-9 
-14 
peritoneal injection of 3H-uridine (25~Ci/100 g body weight) at the time indicated. 
Acid 
soluble 
fraction 
Counts 
699226 
458095 
Acid soluble 
Alkaline plus 
hydrolyzate alkaline Total 
fraction hydrolyzate recoveJzy 
Counts fraction (%) 
Counts 
47815 747041 101 
27156 485251 91 
, BBS3 , or Hot TCA treatment, 0.1 ml .of ·homogenate was solubilized with 0.4 m1 of respective solubilizer as mentioned in Materials 
w and have been substracted in all cases. 
the percentage difference of Counts obtained between the Protosol treatment and the other extraction procedure. The Counts 
extraction procedure were compared wtth the Protosol treatment because of high recovery of Counts by the Protosol treatment. 
N 
w 
I 
Animal 
number 
A 
B 
Time 
(in minutes) 
after 
injection 
20 
40 
Protosol 
treatment 
736830 
50]840 
Table II 
EFFECT OF DIFFERENT SOLUBILIZERS ON THE MEASUREMENT OF TOTAL TISSUE RADIOACTIVITY 
BBS2 
treatment 
678600 
466110 
Difference 
(%) 
-8 
-7 
OF NORMAL RAT KIDNEYS 
Total Counts 
BBS3 
treatment 
595260 
416250 
Difference 
(%) 
-19 
-17 
Hot TCA 
treatment 
671310 
430380 
Difference 
(%) 
-9 
-14 
Acid 
soluble 
fraction 
Counts 
699226 
458095 
Animals received an intraperitoneal injection of 3H-uridine (25~Ci/100 g body weight) at the time indicated. 
Al 
hyd 
fr 
c 
4 
2 
In case of Protosol, BBS2 , BBS3 , or Hot TCA treatment, 0.1 ml . of homogenate was solubilized with 0.4 ml of respective solub 
and Methods. 
Background counts were low and have been substracted in all cases. 
Difference (%) indicates the percentage difference of Counts obtained between the Protosol treatment and the other extractio 
obtained by the different extraction procedure were compared wtth the Protosol treatment because of high recovery of Counts 
From these results it can be concluded that the Protosol treatment 
is the best condition for solubilizing the aliquot of tissue homogenate 
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to measure the total radioactivity and 0.2 N NaOH or 0.3 M KOH can be used 
for the isolation of alkaline hydrolyzate fraction radioactivity. There 
was no significant difference in the counts of alkaline hydrolyzate fraction 
by hydrolyzing the acid insoluble residue with 0. 2N NaOH or 0. 3 M KOH (Table 1). 
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TIME COURSE STUD IE! WITH DIFFERENT LABELED - PRECURSORS 
(A) STUDIES WITH 3H-URIDINE 
Table III shows the time course of incorporation of 3H-uridine into 
different fractions of normal rat kidneys. It is clear that the in-
corporation of uridine is linear for the first 20 minutes but decreases 
beyond this time in all frac.tions (Figure 1). 
A similar type of time course of 3H_.uri.dine incorporation was observed 
in kidneys of adrenalectomized rats (Table IV). The maximum incorporation 
was observed at 20 minutes in all fractions but decreases after this time 
(Figure 2). 
It is rather difficult to compare the magnitude of 3H-uridine in-
corporation into kidneys of normal and adrenalectomized rats.because of 
the small difference and inconsistent incorporation at different times 
after isotope injec~ion. Howev~r it is important to note that the incor-
poration pattern was similar in kidneys of both normal and adrenalectom-
ized rats (Figures 1, 2). 
(B) STUDIES WITH 3H-CYTIDINE 
3 Table V shows the time course of incorporation of H-cytidine into 
different ·fractions of normal rat kidneys. There is an increase in in-
corporation of 3H-cytidine into different fractions for at least 40 min-
utes. Beyon4 this time incorporation plateaus (Figure 3). 
A similar time course of 3H-cytidine incorporation was observed in 
adrenalectomized rat kidneys (Table VI). The maXimum incorporation was 
TABLE III 
TIME COURSE OF INCORPORATION OF 3H-URIDINE INTO DIFFERENT FRACTIONS 
Time in Minutes 
(after injection of isotope)a 
10(2) 
20(4) 
30(2) 
40(2) 
75(2) 
OF NORMAL RAT KIDNEYS 
Total countsb Acid soluble fractio~ 
(cpm/mg. DNA) (cpm/unit O.D2 260 m~) x 1o-J X 10- . 
A. B. 
25.99 ± 12 .. 67 21. 76 ± 10. 33 
50.20 ± 0.98 38.22 ± 1.93 
94.62 ± 10.49 74.93 ± 5.06 
81.19 ± 5. 92 54.10 ± 7.57 
48.97 ;±' 2.20 40.89 ± 1.35 
46.20 ± 2.20 35.36 ± 0.42 
Alkaline hydrolyzat~fraction 
(cpm/mg. DNA) 
x 1o-2 
c. C/A 
4.81 ± 3.25 1.9% 
8.19 ± 0.74 1.6% 
22.81 ± 1.19 2.2% 
19.58 ± 2.04 2.4% 
11.92 ± 2.30 2.4% 
12.53 ± 2.48 2.7% 
All animals received an intraperitoneal injection of 5-3HFuridine - (25 ~Ci/100 g body weight) at the time indicated . 
a Number in parenthesis indicates the number of animals used. 
b Mean ± standard error. 
Figure 1. 
Time course of incorporation of 3H-uridine into the kidneys of 
normal rat. 
All animals received an intraperitoneal injection of 3H-uridine 
(25 ~Ci/100 g body weight) at the designated times before sacrifice. 
The different fractions were separated as mentioned in Materials and 
Methods. 
Specific activity: 
tt tt Total counts (cpm/mg DNA) x 10-3 
~ ~Acid soluble fraction (cpm/unit O.D. 260m~) x 10-2 
()--() Alkaline hydrolyzate fraction (cpm/mg DNA) x 10-2 
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TABLE IV 
TIME COURSE OF INCORPORATION OF 3H-UBIDINE INTO DIFFERENT FRACTIONS 
Time in minutes 
a (after injection of isotope) 
30(3) 
40(2) 
OF ADRENALECTOMIZED RAT KIDNEYS 
Total countsb Acid soluble fraction b 
(cpm/mg. DNA) (cpm/unit O.D. 260 m~) 
x lo-3 X 10-2 
A. B. 
58.54 ± 8.92 47.19 ± 2.12 
73.53 ± 2.51 67.69 ± 9.15 
88.69 ± 6.66 75.04 ± 2.06 
75.51 ± 10.13 58.47 ± 3.96 
62.61 ± 10.74 54.78 ± 0.30 
55 .49 · ± 9.65 32. 9.5 ± 2.10 
Alkaline hydroly~ate 
(cpm/mg. DNA) 
x 10-2 
c. % 
11.13 ± 0.54 
16.95 ± 0.03 
19.65 ± 1.00 
19.14 ± 3.36 
18.36 ± 3.47 
16.76 ± 3.05 
fraction 
C/A 
incorporated 
1.9% 
2.3% 
2.2% 
2.5% 
2.9% 
3.0% 
Animals were used 7 to 8 days after being operated upon. 
3 All animals received an intraperitoneal injection of 5- H~ridine (25 ~Ci/100 g body weight) at the time indicated. 
aNNumber in parenthesis indicates the number of animals used. 
b Mean ± standard error. N 00 
Figure 2. 
3 Time course of incorporation of H-uridine into the kidneys of 
adrenalectomized rat. 
All animals received an intraperitoneal injection of 3H-uridine 
(25 ~Ci/100 g body weight) at the designated times before sacrifice. 
The different · fractions were separated as mentioned in Materials and 
Methods. 
Specific activity: 
tl tiTotal counts (cpm/mg DNA) x 10-3 
. . ~ 
~ ~Acid soluble fraction (cpm/unit O.D. 260m~) x 10 
()--()Alkaline hydrolyzate fraction (cpm/mg DNA) x 10-2 
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TABLE V 
TIME COURSE OF INCORPORATION OF 3H-CJfiDINE INTO DIFFERENT FRACTIONS 
Time in minutes 
(after injection of isotope)a 
5 
10(2) 
20(3) 
40 (2) 
75(2) 
OF NORMAL RAT KIDNEYS 
Total counts b 
(cpm/mg. DNA) 
x lo-4 
A. 
2.09 
9.16 ± 0.49 
12.49 ± 1.32 
14.49 ± 2.69 
13.02 ± 0.17 
Acid Soluble fraction b 
(cpm/unit O.D. 260 m~) 
x 10-3 
B. 
1.45 
7 •. 02 . ± 0.11 
8.56 ± 0.97 
10.21 ± 1.76 
9.11 ±. 0.68 
Alkaline hydrolytiate fraction 
(cpm/mg. DNA) 
10--3 X •. 
c. C/A 
0.20 .95% 
3.96 ± 0.44 4.3% 
9.76 ± 0.81 7.8% 
22.65 ± 1.53 15% 
21.34 ± 5.37 16% 
All animals received an intraperitoneal injection of s-3U-cytidine (25 ~Ci/100 g body weight) at the time indicated. 
a Number in parenthesis indicates the number of animals used. 
b Mean ± standard error. 
w 
0 
I 
Figure 3. 
Time course of incorporation of 3H-cytidine into the kidneys of normal 
rat. 
All animals received an intraperitoneal injection of 3H-cytidine 
(25 ~Ci/100 g body weight) at the designated times before sacrifice. 
The different fractions were separated as mentioned in Materials and 
Methods. 
Specific activity: 
. . ~ Total counts (cpm/mg DNA) x 10 
.. -3 ~ ~Acid soluble fraction (cpm/unit O.D. 260m~) x 10 
()--()Alkaline hydrolyzate fraction (cpm/mg DNA) x 10-3 
·> 
."t: 
> . .- . 
.... 
.;£ 
c..') 
·-...... 
...... 
c..') 
Q) 
Q. 
Cf.) 
20 
- 31 -
• 
• 
* 
* 
10 20 40 75 
TIME (MIN) 
FIGURE 3 
. .. .... .... ·· - ·· .. ·······- -·~ ... --.... . ---· .. ... . , , • • - • " r • • • , .., __ · - ·•• • • • • . ... .. ---.-· ·- ···· ··•····· ..... ...... .. . ---· . 
fABLE VI 
TIME COURSE OF INCORPORATION OF 3H-CYTIDINE INTO DIFFERENT FRACTIONS 
OF ADRENALECTOMIZED RAT KIDNEYS 
Time in minutes Total Counts b Acid Soluble fraction b Alkaline hydrolyzate fraction 
(after injection of isotope)a (cpm/mg. DNA) (cpm/unit O.D. 260 m~) (cppl/mg. DNA)b 
x lo-4 x lo-3 x lo-3 
A. B. c. C/A 
5(2) 6.48 ± 1.·20 4.47 .± 0.90 1.51 ± 0.35 2.3% 
10(2) 7.99 ± 1.54 6. 73 ± 1.48 3.67 ± 0.29 4 .5% 
6.2% 
20{3) 9.36 ± 1.62 8.19 ± 0.92 5.79 ± 0.42 
40(2) 14.05 ± 3.66 11.23 ± 3.45 18.03 ± 5.13 13.0% 
7fl ( 2) 10.83 ± 3.25 7.43 ± .3.80 18. 75. ± o. 25 17.4% - . 
Animals were used 7 to 8 days after being operated upon. 
All animals received an intraperitoneal injection of 5· 3u-c~idine (25 ~Ci/100 g body weight) at the time indicated. 
a Number in parenthesis indicates the number of animals used. 
b Mean ± standard error. 
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observed at 40 minutes (Figure 4). 
Comparison of the magnitude of 3H-cytidine incorporation into differ-
ent fractions of normal and adrenalectomized rat kidneys shows a decrease 
3 in the incorporation of H-cytidine into total and alkaline hydrolyzate 
fraction of adrenalectomized rat kidneys at all the times. 
(C) STUDIES WITH 14c-OROTIC ACID 
14 Table VII shows the time course of incorporation of C-arotic acid 
irito normal rat kidneys. 14 There is an increase in incorporation of C-arotic 
acid into different fractions with increase in time (Figure 5). 
14 A similar time course of C-arotic acid incorporation was observed in 
adrenalectomized rat kidneys (Table VIII). There is a time dependent in-
crease in incorporation into all fractions (Figure 6). 
Comparison of the magnitude of 14c-orotic acid into different fractions 
of normal and adrenalectomized rat kidneys shows a general decrease in the 
incorporation of labeled precursor into the kidneys of adrenalectomized rats. 
In all these studies, the incorporation of isotopes was linear for at 
least 20 minutes. 3 In studies with H-uridine the incorporation beyond 20 
minutes decreases whereas with 3H-cytidine and 14c-orotic acid there is an 
increase in incorporation after 20 minutes. 
Table IX shows the relative efficiencies of various RNA precursors 
in pulse labeling of kidney RNA of normal and adrenalectomized rats. 
With an identical 20 minutes incorporation period labeled orotic acid and 
cytidine are more efficiently incorporated into RNA than the labeled 
uridine. In further studies with hormones only 3H-cytidine and 14c-orotic 
acid were used and a standard time of 20 minutes was chosen. 
Figure 4. 
Time course of incorporation of 3H-cytidine into the kidneys of 
adrenalectomized rat. 
All animals received an intraperitoneal injection of 3H-cytidine 
(25 ~i/100 g body weight) at the designated times before sacrifice. 
The different fractions were separated as mentioned in Materials and 
Methods. 
Specific activity: 
• 
-4 e Total counts (cpm/mg DNA) x 10 
~ ~Acid soluble fraction (cpm/unit O.D. 260m~) x 10-3 
()---()Alkaline hydrolyzate fraction (cpm/mg DNA) x 10-3 
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TABLE VII 
TIME COURSE OF INCORPORATION OF:! l 4c-OROTIC ACID INTO DIFFERENT FRACTIONS 
Time in minutes 
(after injection of isotope)a 
5 
10(2) 
20(5) 
40(4) 
75 (2) 
OF NORMAL RAT KIDNEYS 
TC!tal Counts b 
(cpm/mg. DNA) 
X 10...;4 
A. 
7.84 ± 1. 39 
11.48 ± 0.85 
17.35 ± 1.59 
19.35 ± 0.64 
23.17 ± 0.81 
Acid Soluble fractio~ 
(cpm/unit O.D. 260 m~) 
x lo-3 
B. 
5.25 ± 0.22 
8.17 ± 0.69 
12.64 ± 1.42 
15.44 ± 0.72 
18.02 ± 0.90 
Alkaline hydrolyzate fraction 
(cpm/mg. DNA)0 
x lc-3 
c. C/A (%) 
3.95 :!: 2.69 5 
3.25 ± 0.40 2.8 
8.86 ± 0.44 5.~ 
12.75 ± 1. 47 6.6 
18.73 ± 1~30 8.1 
14 All animals received an intraperitoneal injection of C-erotic acid (5 ~Ci/100 g body weight) at the time indicated 
a Number in parenthesis indicates the number of animals used. 
b Mean ± standard error. 
w 
U1 
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Figure 5. 
Time course of incorporation of 14c-orotic acid into the kidneys of 
normal rat. 
All animals received an intraperitoneal injection u~ 14c-orotic acid 
(5 ~Ci/100 g body weight) at the designated times before sacrifice. 
The different fractions were separated as mentioned in Materials and 
Methods. 
Specific activity: 
e e Total counts (cpm/mg DNA) x 10-4 
* *Acid soluble fraction (cpm/unit O.D. 260 m~) x 10-3 
()--()Alkaline hydrolyzate fraction (cpm/mg DNA) x 10-3 
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TABLE VIII 
TIME COURSE OF INCORPORATION OF 14C-OROTIC ACID INTO DIFFERENT FRACTIONS 
Time in minutes 
a (after injection of isotope) 
5(2) 
10(3) 
20(6) 
40(3) 
75(3) 
OF ADRENALECTOMIZED RAT KIDNEYS 
Total Countsb 
(cpm/mg. DNA) 
x lo-4 
A. 
5.95 ± 0.78 
10.16 ± 0.58l 
15.01 ± 1.13 
28.21 ± 1.20 
25.89 ± 5.35 
Acid Soluble fractio~ 
(cpm/unit O.D. 260 m~) 
x lo-3 
B. 
4.21 ± Ol05 
6.56 ·± 0.64 
10.94 ± 0.688 
18.54 ± 0.68 
16.19 ± 3.45 
Animals were used 7 to 8 days after being operated upon. 
Alkaline hydrolyzate fraction 
(cpm/mg. DNA) b 
x lo-3 
c. C/A 
3.19 ± 0.96 5.4% 
2.95 ± 0.29 3.0% 
8.17 ± 0.63 5.5% 
13.70 ± 0.54 4.9% 
17.09 ± 2.92 6.6% 
All animals reeeived an intraperitoneal injection of 14c-orotic acid (5 ~Ci/100 g body weight) at t he times i ndicated. 
a Number in parenthesis indicates the number of animals used. 
b Mean ± standard error. 
Figure 6. 
Time course of incorporation of 14c~orotic acid into the kidneys of 
adrenalectomized rat. 
All animals received an intraperitoneal injection of 14c-orotic acid 
(5 ~Ci/100 g body weight) at the designated times before sacrifice. The 
different fractions were separated as mentioned in Materials and Methods. 
Specific activity: 
tt Ct Total counts (cpm/mg DNA) x 10-4 
~ ~Acid soluble fraction (cpm/unit O.D. 260 ~) x 10-3 
C)--C) Alkaline hydrolyzate fraction (cpm/mg DNA) x 10-3 
> 
....., 
·-> 
·-~ 
(.;) 
·-
..,_ 
·-(.;) 
Q) 
ca. (J) . 
- 38 -
10 20 40 75 
TIME (MIN) 
FIGURE 6 
•• • ' ' • • • ••v • 
····- -··· · ... ·~ -··· ..... ...... -..... .... .. . 
TABLE IX 
RELATIVE EFFICIENCIES OF VARIOUS RNA PRECURSORS IN PULSE LABELIN~ OF KIDNEY RNA 
Precursor 
3 5- H-Uridine 
3 5- H-Cytidine 
14 6- c-orotic acid 
a Dose 
1-JC.i }lmo le 
25 0.0009 
25 0.0009 
25 0.0250 
25 0.0250 
5 0.0822 
5 0.0822 
Precursor 
incorporation 
time 
(minutes) 
20 
20 
20 
20 
20 
20 
Category of 
animals 
Normal 
Adrenalectomized 
Normal 
Adrenalectomized 
Normal 
Adrenalectomized 
a Amount of precursor administered per 100 g bodv weight. 
Adrenalectomized rats were used 7 to 8 days after being operated upon. 
(A) 
Acid soluble 
fraction 
(cpm/mg DNA) 
x lo-3 
98.81 
93.18 
137.96 
102.48 
165.98 
150.52 
(B) 
Alkaline 
hydrolyzate 
fraction 
(cpm/mg DNA) 
X·l0-3 
2.28 
1.96 
9.76 
5.79 
8.86 
8.17 
Incorporation 
effeciency 
B/A X 100 
2.30 
2.10 
7.07 
5.64 
5.33 
5.42 
- 4 0 -
EFFECT OF ADRENALECTOMY AND ALDOSTERONE TREATMENT ON ACID SOLUBLE POOL 
AND RNA OF RAT KIDNEYS 
Table X shows the effect of adrenalectomy and aldosterone treatment on 
acid soluble nucleotide pool:DNA and RNA:DNA ratio of rat kidneys. There 
is a significant decrease in RNA:DNA ratio of adrenalectomized rats as 
compared to normal animals. Administration of aldosterone to adrenalecto-
mized rats for 1 or 2 hours (and 20 minutes isotope incorporation) before 
sacrifice increased RNA:DNA ratio to levels even greater than normal (Figure 
7). There was no change in the acid soluble nucleotide pool:DNA ratio 
after adrenalectomy and aldosterone treatment. It can be concluded that 
mav 
adrenalectomy/cause lower rates of RNA synthesis which can be increased 
by aldosterone treatment. 
STUDIES WITH HORMONES 
Table XI shows the effect of adrenalectomy and aldosterone treatment 
3 
on the incorporation of H-cytidine into rat kidneys. There is a decrease 
in incorporation of precursor into total and alkaline hydrolyzate fraction 
after adrenalectomy, No decrease in incorporation into the acid soluble 
pool was observed. Administration of aldosterone either 1 or 2 hours 
before the isotope results in an increased incorporation of precursor 
into all fractions. Aldosteronetreatment increases the incorporation into 
total and acid soluble fractions to levels even greater than normal 
(Figure 8). It can be concluded that aldosterone increases the rate of 
precursor uptake and subsequent incorporation into alkaline hydrolyzate 
fraction in the kidneys of adrenalectomized rats. 
a Category of animals 
Normal (31) 
Adrenalectomized (33) 
Adrenalectomized plus 
aldosterone treated 
1 hour (9) 
2 hours (8) 
- ••···- .•• . _1., .., •.•.. . . , ,. " "" "'·"· '• -' ! :"· '.T •· · ·· · ~ · • . .. •• . , ··-- · ·· • · 
TABLE X 
EFFECT OF ADRENALECTOMY AND ALDOSTERONE TREATMENT ON ACID SOLUBLE 
NUCLEOTIDE POOL: DNA AND RNA: DNA RATIO OF RAT KIDNEYS 
b c Acid soluble pool :DNA 
13.98 ± 0.33 
13.55 ± 0.34 
13.92 ± 0.32 
14.61 ± 0.29 
Difference 
(%) 
-3 
+3 
+8 
p value RNA:DNAc 
N.S. 0.947 ± 0.024 
0.784 ± 0.023 
N.S. 0.947 ± 0.058 
N.S. 0.993 ± 0.062 
Difference p value 
(%) 
-17t <0.05 
+2ltt <0.05 
+27tt <0.05 
Adrenalectomized rats were used 7 to 8 days after being operated upon. Aldosterone (5 ~g/100 g body weight) was injected 
intraperitoneally to adrenalectomized rats 1 hour and 2 hours prior to the4isotope injection. All animals received an intraperitoneal injection of 5-3H-cytidine (25 ~Ci/100 g body weight) or 1 C-arotic acid (5 ~Ci/100 g body weight) 20 
minutes before sacrifice to also study the precursor uptake (Tables XI, XII, and XIV). 
a Number in parenthesis indicates the number of animals used •. 
b Measured as optical density at 260 m~. 
c Mean ± standard error. 
p value was calculated by the student t test method. 
t Normal - adrenalectomized 
++;:Adrenalectomized-adrenalectomized nlus aldo!::terone trP.~.tP.r'l. 
Figure 7. 
Effect of adrenalectomy and aldosterone treatment on acid soluble 
nucleotide pool: DNA and RN~: DNA ratio of rat kidneys. 
Adrenalectomized rats were used 7 to 8 days after being operated upon. 
Saline or aldosterone (5 ~g/100 g body weight) was injected to 
adrenalectomized (ADX) rats 1 hour and 2 hours prior to the isotope 
injection. All animals received an intraperitoneal injection of 
3 14" H-cytidine (25 ~Ci/100 g body weight) or C-orotic acid (5 ~Ci/100 g 
body weight) 20 minutes before sacrifice to also study the precursor 
uptake (Tables XI, XII, and XIV). 
Results are expressed as percentage of normal = 
(:]-acid soluble nucleotide pool:DNA ratio 
mm- RNA:DNA ratio 
Experimental x lOO. 
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TABLE XI 
EFFECT OF ADRENALECTOMY AND ALOOSTERONE TREATMENT ON THE INCORPORATION 
OF 3H-CYTIDINE INTO DIFFERENT FRACTIONS OF RAT KIDNEYS 
a Adrenalectomized(3) 
tDifference 
( % ) 
8Adrenalecomized & 
Hormone Treatment 
1 hr. (5) 2 hr. (4) 
ttDifference (%) 
1 hr. 2 hr. 
-------- ·- - --
Total counts b 
(cpm/mg. DNA) 
X 10-4 
12.49 ± 1. 32 
Acid Soluble fraction 
(epm/unit OD 260 m~)b 
x lo-3 
8.56 ± 0.97 
Alkaline hydrolyzate 
(cpm/mg. DNA)bffaattmnn 9.76 ± 0.81 
x 1o-J 
9.36 ± 1.62 
8.19 ± 0.92 
5.7'9 ± 0.42 
-25 14.05 ± 1.14 13.60 ± 0.67 +50 +45 
-4 10.94 ± 0.66 11.09 ± 0.48 +34 +35 
-41 8.84 ± 0.95 9.00 ± 1.77 +53 +56 
Adrenalectomized rats were used 7-8 days after being operated upon. Aldosterone (5 pg/100 g bod~ weight} was injected 
intraperitoneally to adrenalectomized rats 1 hour and 2 hours pr~ar to the isotope injection. All animals received intra-
peritoneal injection of 5-3H-cytidine (25 pCi/100 g body weight) 20 minutes before sacrifice. 
a Number in parenthesis indicates the number of animals used. 
b Mean ± standard error. 
t Normal - adrenalectomized 
tt Adrenalectomized - adrenalectomized plus aldosterone treated 
Figure 8. 
Effect of adrenalectomy and aldosterone treatment on the incorporation 
3 
of H-cytidine into different fractions of rat kidneys. 
Adrenalectomized rats were used 7 to 8 days after being operated upon. 
Saline or aldosterone (5 ~g/100 g body weight) was injected intraperi-
toneally to adrenalectomized (ADX) rats 1 hour and 2 hours prior to the 
isotope injection. All animals received an intraperitoneal injection 
3 
of H-cytidine (25 ~Ci/100 g body weight) 20 minutes before sacrifice. 
Results are expressed as percentage of normal specific activity = 
Experimental 
Normal X 100. 
[:) Total counts (cpm/mg DNA) 
~ Acid soluble fraction (cpm/unit O.D. 260m~) 
Dmm Alkaline hydrolyzate fraction (cpm/mg DNA) 
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Tables XII and XIII show the effect~·of adrenalectomy, aldosterone, 
deoxycorticosterone, corticosterone and cortisol on the incorporation 
14 
of C-orotic acid into different fractions of rat kidneys. There is a 
-45 -
small general decrease in incorporation of precursor after adrenalectomy. 
Administration of aldosterone 1 or 2 hours before the isotope results in 
a marked increase in incorporation of precursor into all fractions. 
Administration of deoxycorticosterone or corticosterone 1 or 2 hours 
prior to the isotope results in an increased incorporation of precursor 
into total and acid soluble fractions. There was no difference observed 
in the incorporation of alkaline hydrolyzate fraction. On the other hand, 
administration of cortisol 1 or 2 hours before the isotope causes a 
decrease in incorporation of pteaitsor into total and alkaline hydrolyzate 
fraction, whereas the incorporation into acid soluble fraction was 
unchanged (Figure 9). It can be concluded from these studies that aldo-
sterone causes a marked increase in the rate of precursor uptake and 
subsequent incorporation into alkaline hydrolyzate fraction. There may 
also be a genuine increase in RNA s1nthesis after aldosterone treatment. 
Deoxycorticosterone and corticosterone cause an increase in the rate of 
precursor uptake whereas cortisol inhibits the uptake of precursor into the 
kidneys of adrenalectomized rats. 
STUDIES WITH ACTINOMYCIN D AND ALDOSTERONE 
Table XIV shows the effect of actinomycin D and aldosterone treatment 
on the incorporation of 14c-orotic acid into the kidneys of adrenalectomized 
rats. Administration of aldosterone 2 hours prior to the isotope results 
TABLE XII 
EFFECT OF ADRENALECTOMY, ALDOSTERONE AND DEOXYCORTICOSTERONE TREATMENT ON THE 
INCORPORATION OF 14c-OROTIC ACID INTO DIFFERENT FRACTIONS OF RAT KIDNEYS 
Adrenal-
ectomized 
a aAdrenal- tDiffer- and hormone 
Fraction Normal (5) ectomized (6) ence (%) treatment 
Total countsb 
(cpm/mg DNA) 
x lo-4 17.35 ± 1.59 15.01 ± 1.13 
Acid soluble fraction 
(cpm/unit OD 260 m~)b 
x lo-3 12.64 ± 1.43 10.94 ± o.68 
Alkaline hydrolyzate 
fraction b _3 (cpm/mg DNA) x 10 8.86 ± 0.44 8.17 ± 0.63 
- 14 1 hr 
2 hrs 
- 13 1 hr 
2 hrs 
-8 1 hr 
2 hrs 
a Aldosterone 
1 hr (4) 
2 hr (5) 
19.63 ± 0.57 
20.64 ± 2.42 
14.59 ± 1.25 
14.22 ± 1.58 
13.76 ± 2.42 
13.93 ± 3.74 
ttDiffer- ~eoxycorti- tttDiffer-
ence(%) costerone (3) ence(%) 
+ 31 16.30 ± 0.84 +9 
+ 38 14.79 ± 0.97 
+ 33 15.05 ± 1.03 +38 
+ 30 13.34 ± 0.74 +22 
+ 68 7.66 ± 0.17 - 6 
+ 70 7.53 ± 0.31 - 8 
Adrenalectomized rats were used 7 to 8 days after being operated upon. Aldosterone (5 ~g/100 g body weight) or deoxycorti-
costerone (100 ~g/100 g body weight) was injected intraperitoneally to adl~nalectomized rats 1 hour and 2 hours prior to 
the isotope injection. All animals received intraperitoneal injection of C-orotic acid (5 ~Ci/100 g body weight) 20 
minutes before sacrifice. 
a Number in parenthesis indicates the number of animals used. 
b Mean ± standard error. 
t Normal - adrenalectomized 
tt Adrenalectomized - adrenalectomized plus aldosterone treated 
ttt Adrenalectomized ~ adrenalectomized ~lus deoxvcorticosterone treated 
TABLE XIII 
EFFECT OF ADRENALECTOMY, CORTICOSTERONE AND CORTISOL TREATMENT ON THE INCORPORATION 
OF 14c-OROTIC ACID INTO DIFFERENT FRACTIONS OF RAT KIDNEYS 
---------- ----
Adrenal-
Fraction ~orma1(5 ) a tDiffer- ectomized a ttDiffer a Adrenal- Corti- Cortisol(3)tttDi ffer-
ectomized(6)ence (%) and hormone costerone(l) ence (% ) ence{%) treatment 
---- ------ --------
Total countsb 
17.35 ± 1.59 15.01 ± 1.13 -14 1 hr. 16.59 ± 1.93 +11 13.22 1.26 -12 (cpm/mg DNA) ± 
X 10-4 2 hrs. 17.14 ± 1.19 +14 12.05 ± 1.49 -20 
Acid soluble fraction 
(cpm/unit O.D. 260mJ) b 1 hr. 14.34 ± 2.55 +31 10.79:!: 1.00 
X 10'""3 12.64 ± 1.43 10.94 ± 0.68 -13 2 hrs. 15.43 ± 0.69 +41 10.92 ± 1. 71 
Alkaline hydrolyzate 
(cpm/mg DNA)bfraction 8.86 ± 0.44 8.17 ± 0.63 -8 1 hr. 8.05 ± 1.61 6.23 ± 1.20 -24 
X l0-3 2 hrs. 7.40 ± 0.82 -9 6.22 ± 1.56 -24 
------------------------------------- --------------------
Adrenalectomized rats were used 7-8 days after being operated upon. Corticosterone (2: .mg/100 g body weight} or cortisol 
(2 mg/100 g body weight) was injected intraperitoneally to adrenalectomized rats 1 hour and 2 hours prior to the isotope 
injection. All animals received intraperitoneal injection ofl4c-orotic acid (5 pCi/100 g body weight) 20 minutes before 
sacrifice. 
~umber in parenthesis indicates the number of animals used. 
bMean ± standard error. 
tNormal - adrenalectomized 
ttAdrenalectomized - adrenalectomized plus corticosterone treated 
tttAdrenalectomized - adrenalectomized plus cortisol t r eated 
Figure 9. 
Effect of adrenalectomy, aldosterone, deoxycorticosterone, corticosterone 
and cortisol treatment on the incorporation of 14c-orotic acid into 
different fractions of rat kidney. 
Adrenalectomized. rats were used 7 to 8 days after being operated upon. 
Salin~, aldosterone (5 ~g/100 g body weight), deoxycorticosterone 
(100 ~g/100 g body weight) corticosterone (2 mg/100 g body weight) or 
cortisol (2 mg/100 g body weight) was injected intraperitoneally to 
adrenalectomized (ADX) rats 1 hour and 2 hours prior to the isotope 
injection. All animals received an intraperitoneal injection of 14c-orotic 
.. 
acid (5 ~Ci/100 g body weight) 20 minutes before sacrifice. 
Results are expressed as percentage of normal specific activity = 
Experimental 
Normal X 100. 
c:J Total counts (cpm/~g DNA) 
E§i Acid soluble fraction (cpm/unit O.D. 260 m~) 
mna Alkaline hydrolyzate fraction (cpm/mg DNA) 
-C'a. 
E 
~ 
c 
2 
. ~DXplus · 
Hormone 
Treatment 
ALDOSTERONE . 
1 hr 2 hrs 
DEOXYCORTICOSTERONE . CORTICOSTERONE CORTISOL 
l hr . 2 hrs 1 hr . . . 2. tys' ·. _. . . 1 hr 2 hrs 
TABLE XIV 
:---··-"· - ·-EFFECT OF ACTINOMYCIN D AND ALDOSTERONE TREATMENT ON THE INCORPORATION OF 14C-OROTIC ACID 
:ion 
a Adrenalectomized 
(3) 
15.85 ± 0.50 
12.03 ± 0.44 
7.23 ± 0.74 
INTO DIFFERENT FRACTIONS OF ADRENALECTOMIZED RAT KIDNEYS 
a Aldosterone 
treated. (3) 
21.20 ± 1.26 
14.56 ± 0.44 
13.05 ± 1.41 
t Difference 
(%) 
+34 
+21 
+80 
a Actinomycin D 
treated (3) 
15.62 ± 0.73 
11.55 :!: 0.63 
3.39 ± 0.18 
tt Difference 
(%) 
-4 
-53 
a Actinomycin D 
plus 
Aldosterone 
treated (3) 
18.39 ± 1.08 
13.80 :!: 0.99 
3.56 ± 0.25 
ttt Difference 
( %) 
+16 
+15 
-51 
~d 7-8 days after being operated upon. Saline, Aldosterone (5 ~gflOO g body weight), Actinomycin D (50 ~g/100 g bddy weight) 
I ~g/100 g body weight) plus Aldosterone (5 ~~/100 gobody weight) were injected· intraperitoneally 2 hours prior to the isotope 
tals received intraperitoneal injection· of C-arotic acid (5 ~Ci/100 g body weight) 20 minutes b~fore sacrifice. 
~sis indicates the number of animals used. 
~ror. 
· adrenalectomized plus aldosterone treated 
- adrenalectomized plus actinomycin D treated 
. - adrenalectomized plus actinomycin D and aldosterone treated 
TABLE XIV 
-- ... 1----- · ·---~-, - -:--··-·-·-·--·EFFECT OF ACTINOMYCIN D AND ALDOSTERONE TREATMENT ON THE INCORPORATION OF 14c-OROTIC ACID 
Fraction 
Total Counts b 
(cpm/mg. DNA) 
X lo-4 
Acid Soluble Fraction b 
(cpm/unit O.D. 260m~) 
x lo-3 
Alkaline hydrolyzate 
(cpm/mg. DNA~b fraction 
X 10-
a Adrenalectomized 
(3) 
15.85 ± 0.50 
12.03 ± 0.44 
7.23 ± 0.74 
INTO DIFFERENT FRACTIONS OF ADRENALECTOMIZED RAT KIDNEYS 
a Aldosterone 
treated. (3) 
21.20 ± 1.26 
14.56 ± 0.44 
13.05 ± 1.41 
t Difference 
(%) 
+34 
+21 
+80 
a Actinomycin D 
treated (3) 
15.62 ± 0.73 
11.55 :!: 0.63 
3.39 ± 0.18 
t t Difference 
(%) 
-4 
-53 
a Actinomycin D 
plus 
Aldosterone 
treated (3) 
18.39 ± 1.08 
13.80 ± 0.99 
3.56 ± 0.25 
All animals were used 7-8 days after being operated upon. Saline, Aldosterone (5 ~gflOO g body weight), Actinomycin D (50 ~g/100 l 
or Actinomycin D (50 ~g/100 g body weight) plus Aldosterone (5 ~~/100 gobody weight) were injected· intraperitoneally 2 hours prior 
injection. All animals received intraperitoneal injection of C-arotic acid (5 ~Ci/100 g body weight) 20 minutes b~fore sacri f i c 
a Number in parenthesis indicates the number of animals used. 
b Mean ± standard error. 
t Adrenalectomized - adrenalectomized plus aldosterone treated 
tt Adrenalectomized - adrenalectomized plus actinomycin D treated 
ttt Adrenalectomized - adrenalectomized plus actinomycin D and aldosterone treated 
\ \ 
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in an increase in incorporation of precursor into all the fractions, as 
shown also in Table XII. Actinomycin D treatment 2 hours before the 
isotope causes a marked decrease in incorporation into the alkaline 
hydrolyzate fraction. No such decrease in incorporation was observed in 
total or acid soluble fractions. Administration of actinomycin D plus 
aldosterone 2 hours prior to the isotope causes an increase in incorpor-
ation of total and acid soluble fraction whereas there was still a marked 
decrease in the incorporation of labeled precursor into alkaline 
hydrolyzate fraction (Figure 10). It can be concluded that aldosterone 
increases the rate of precursor uptake to a greater level when RNA 
synthesis is not inhibited by actinomycin D treatment. 
Figure 10. 
Effect of actinomycin D and aldosterone treatment on the incorporation 
14 
of C-orotic acid into different fractions of adrenalectomized rat 
kidneys .• 
All animals were used 7 to 8 days after adrenalectomy. 
Saline, aldosterone (5 l.l g/100 g body weight), actinomycin D (50 l.l g/100 g 
body weight) or actinomycin (50 l.lg/100 g body weight) plus aldosterone 
(5 ~g/100 g body weight) were injected intraperitoneally 2 hours prior to 
the isotope injection. All animals received an intraperitoneal injection 
of 14c-orotic acid (5 ~Ci/100 g body weight) 20 minutes before sacrifice. 
Results are expressed as percentage of control specific activity = 
Experimental 
Control X 100. 
r:J. Total counts (cpm/mg DNA) 
~ Acid soluble fraction (cpm/unit O.D. 260 m~) 
-IIIII Alkaline hydrolyzate fraction (cpm/mg ;DNA) 
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DISCUSSION 
TIME COURSE STUDIES WITH LABELED PRECURSORS: 
Many workers have used labeled nucleosides for studies of the synthesis 
of RNA in biological systems (90, 118, 130). The rate of incorporation of 
these precursors into acid precipitable material or RNA is generally taken 
as a measure of the rate of RNA synthesis by the cells. Nucleosides, 
however, are not direct precursors of RNA and it is possible, therefore, 
that changes in the capacity of the cell to take up or phosphorylate nucleo-
· sides to nucleoside triphosphates might cause changes in the rate of 
incorporation of nucleoside into RNA unrelated to the rate of RNA synthesis. 
There is also the possibility that the net pool of nucleotides might change. 
This, even if accompanied by no change in the rate of uptake of phosphory-
lation, results in a change in the specific activity of the pool and hence 
in the RNA synthesized. 
Table IX shows the results in which we compared the incorporation 
3 3 14 
efficiency of H-uridine, H-cytidine and C-orotic acid into RNA of normal 
and adrenalectomized rat kidneys. 
Under experimental conditions, orotic acid and cytidine are more 
efficiently incorporated than uridine with an identical 20 minutes time 
incorporation. It seems that orotic acid and cytidine are more effective 
for long term incorporation studies, as is shown by the steady rise in 
specific radioactivity of the alkaline hydrolyzate fraction (Figures 3-6). 
It is rather difficult to commpare the magnitude of 3a-uridine incor-
poration into kidneys of normal and adrenalectomized rats because of the 
inconsistent incorporation at different times after isotope injection. 
In this respect, uridine incorporation is different from either cytidine 
or orotic acid incorporation. The difficulties encountered with uridine 
incorporation are related to its anomalous uptake kinetics; maximum uptake 
was not only earlier but also far less efficient than with the cytidine 
and orotic acid. 
The rate of uridine incorporation was almost linear up to 20 minutes 
and decreased markedly to lower levels after this time. The reason for 
this decrease in uridine incorporation is not known, but it might be a 
consequence of the initiation of regulatory controls either on uptake of 
uridine or its phosphorylation as has been suggested by Plagemann for 
Novikoff rat hepatoma growing cells (130). 
On the other hand, the incorporation of cytidine and orotic acid 
increased with time up to 40 minutes and then leveled off. There was 
a decrease in the incorporation of these precursors into the alkaline 
hydrolyzate fraction of adrenalectomized rat kidneys as compared to the 
normal animals which suggests a slower rate of RNA synthesis 1n the kid-
neys of adrenalectomized rats. 
These results emphasize the necessity of precursors of high specific 
radioactivity as well as the importance of the type of pyrimidine pre-
cursor employed. 
EFFECT OF ADRENALECTOMY AND ALDOSTERONE TREATMENT ON ACID SOLUBLE 
NUCLEOTIDE POOL AND RNA OF RAT KIDNEYS: 
Several workers have demonstrated that an early response to aldo-
sterone involves an increase in the rate of RNA synthesis, which has been 
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measured as an increase in the radioactive .precursor incorporation into 
RNA (115, 112). The inhibition of RNA synthesis by actinomycin D has 
been found to prevent the action of aldosterone on sodium transport (110, 
113). It was of interest to determine whether there is any change in RNA 
metabolism of adrenalectomized and aldosterone treated rat kidneys. 
As shown in Table X, a significant decrease in RNA: DNA ratio was 
observed in the kidneys of a4renalectomized rats as compared to the nor-
mal animals. This decrease in RNA: DNA ratio can be restored by a single 
injection of aldosterone either 1 or 2 hours prior to the isotope injection. 
These findings are similar to the reported decrease in RNA:DNA ratio in 
seminal vesicle and prostate gland after castration and in the uterus 
after ovariectomy~ . !he RNA:DNA ratio of these tissues has been restored 
to normal value after administration of appropriate hormones (131-134). 
The increase in RNA content after 1 hour of aldosterone treatment pre-
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cedes the repo=ted effect of aldosterone in increasing sodium transport (112). 
In these studies, no change in acid soluble pool:DNA ratio was observed 
after adrenalectomy or aldosterone treatment. 
The decrease in RNA:DNA ratio of adrenalectomized rats must indicate 
lower rates of RNA synthesis as it has been shown that RNA in various 
subcellular fractions has a slower turnover rate (135) and also that RNA 
polymerase activity is lower in the kidneys of adrenalectomized rats (136,137). 
The decrease in the rate of RNA synthesis in adrenalectomized rats may 
result in a decrease in the rate of specific protein synthesis which could 
account for the decrease in sodium retention in adrenalectomized rats since 
the demonstrated increase in RNA and protein synthesis induced by aldo-
sterone treatment has been related to the increase in sodium retention 
(110,113). 
The increase in RNA:DNA after aldosterone treatment may indicate 
increased rate of RNA synthesis in the kidneys of adrenalectomized rats. 
These studies give further support to the postulated hypothesis that 
aldosterone acts through the RNA and protein synthesis. 
EFFECT OF ADRENALECTOMY AND ALDOSTERONE TREATMENT ON THE INCORPORATION 
OF RADIOACTIVE PRECuRSORS INTO RAT KIDNEYS: 
3 Adrenalectomy causes a decrease in the incorporation of H-cytidine 
into alkaline hydrolyzate fraction. No such decrease in incorporation 
into the acid soluble pool was observed. Administration of aldosterone 
either 1 or 2 hours before the isotope results in an increased incor-
poration of precursor into macromolecular RNA (Table XI). However, there 
is also a marked stimulation of uptake of precursor into the acid soluble 
1 Simil 1 h 1 b b d b · ~4c i id poo • ar resu ts ave a so een o serve y us1ng -orot c ac 
as a precursor (Table XII). The increased uptake is sufficient to account 
3 for at least 65% of the stimulation of H-cytidine and 45% of the stimu-
14 lation of C-orotic acid incorporation. There may also be a genuine 
increase in R~A synthesis but its magnitude is less than would be assumed 
if the acid insoluble incorporation alone were measured. 
These studies are similar to the reported increase in incorporation 
of precursor into the RNA fraction. Castles and Williamson (lil) reported 
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a stimulation by aldosterone of the in vivo incorporation of 14c-orotic 
acid into rat renal microsomal RNA. Their experimental design differs 
in several respects from the one described in this thesis. These workers 
injected subcutaneously a much lower dose of aldosterone (0.34 ~/kg body 
weight) after the intravenous administration of 14c-orotic acid. 
Fimognari et aZ (112) reported similar results. Following the sub-
cutaneous injection of 2 ~ aldosterone into adrenalectomized rats, the 
rate of incorporation of 3H-orotic acid into various fractions of kidneys 
was determined in vitro. They reported an increase in activity in the 
nuclear fraction (not signifiant) 1 hour after hormone injection, and a 
significant increase was observed at 1.5 hours of hormone administration. 
Forte and Landon (43) injected 22 lJg aldosterone intravenously into 
adrenalectomized rats and assayed for an effect of the hormone on the 
in vivo incorporation of 14c-orotic acid into RNA fractions obtained at 
different temperatures. They reported a significant stimulation in incor-
poration at 30 and 60 minutes after administration of aldosterone. By 2 to 
3 hours after aldosterone administration the incorporation of 14c-orotic acid 
into RNA was again approaching the control levels. Their experimental design 
also differs from the one described in this thesis. Our design was an intra-
peritoneal injection of aldosterone (5 J,lg/100 g body weight), followed by 
* intraperitoneal injection of precursor 20 minutes before sacrifice. 
* This experimental design is better because incorporation of exogenous 
precursors plateaus after about 20 minutes and hence beyond this time one is 
not necessarily measuring the rate of incorporation. 
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By keeping in mind the differences in experimental design between the 
reported workers and ourselves, it is of interest to note that we observed 
a marked stimulation in incorporation into RNA after 1 hour of hormone 
treatment which persists at least for 2 hours after hormone administration. 
Furthermore, in our studies we have also shown an increase in precursor 
uptake into acid soluble pool after hormone treatment. 
Initially, it was felt that 5 ~g of aldosterone might represent a 
pharmacological dosage. However, Friedman et at (138, 139) injected 
aldosterone in doses of 5 to 10 ~g/100 g body weight. This was considered 
to be a reasonable maintenance dose for adrenalectomized rats (140). 
Fimognari et at (112) injected 2 ~g aldosterone subcutaneously whereas Forte 
and Landon (43) administered 22 ~g aldosterone intravenously into adrenal-
ectomized rats and studied the effect of the hormone on renal RNA synthesis. 
The 5 ~g dose of aldosterone used in the reported studies discussed in 
this thesis is within the dose range reported in the literature and it is 
likely that 5 ~g of aldosterone is a physiological dose. 
EFFECT OF ACTINOMYCIN .D AND ALDOSTERONE TREATMENT ON THE INCORPORATION OF 
14c~OROTIC ACID IN ADRENALECTOMIZED RAT KIDNEYS: 
Actinomycin D has been shown to have no effect on sodium excretion by 
itself, but significantly inhibits the antinatrlur~ic action of aldosterone 
(113, 112). Incorporation of 14c-orotic acid into acid soluble pool 
and alkaline hydrolyzate fraction following actinomycin D and/or aldosterone 
is shown in Table XIV. Aldosterone increases the incorporation 
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of 14c-orotic acid into all fractions. When the actinomycin D treated 
group was compared with the control group, a significant decrease in the 
incorporation of precursor was observed in the alkaline hydrolyzate fraction. 
There was no such decrease in incorporation into .the acid soluble pool. Treat-
ment with actinomycin D plus aldosterone was still found to decrease the in-
corporation into alkaline hydrolyzate fraction whereas there was a small 
increase in precursor uptake into the acid soluble pool fraction. 
These studies suggest that most of the apparent stimulatory effect of 
aldosterone on RNA synthesis is due to the changes in the rate of precursor 
uptake. This means that the previously observed effect of aldosterone (111, 
112) on precursor incorporation doe~ not necessarily indicate a stimulation 
of RNA synthesis. Several other reports of hormonal stimulation appear to 
be due to increased uptake of precursor. Means and Hamilton (23, 24) 
concluded that the early increase in uterine RNA synthesis in response to 
estrogen was due to increased uridine uptake and Billing et aZ (30) could 
detect no increase in RNA synthesis in uterine tissue until 5 hours after 
estrogen administration if correction were made for changes in the specific 
activity of the uridine pool. Yu and Feigelson (28) showed an increase in 
the orotate transport after cortisone treatment without observing any 
change in the size of the acid soluble pool. Miller and Baggett (29) also 
concluded that estrogen primarily increases the incorporation of nucleosides 
into nucleotide pools without changing the size of the total free nucleotide 
pool of mouse uterus during the first 6 hours of hormone treatment~ 
However, we cannot rule out the possibility that aldosterone also 
stimulates the RNA synthesis, particularly in the light of increased 
RNA:DNA ratio after aldosterone treatment (Table X). These results are 
also consistent with the reported increase in RNA polymerase activity 
following aldosterone treatment (136, 137). 
EFFECT OF DEOXYCORTICOSTERONE, CORTICOSTERONE AND CORTISOL ON THE 
INCORPORATION OF 14c-OROTIC ACID INTO ADRENALECTOMIZED RAT KIDNEYS: 
The adrenal corticoids,being very similar in structure show some 
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overlap in activity. For example, liver glycogen deposition is influenced 
by cortisol, corticosterone, and aldosterone (67). These hormones also 
have the ability to influence Na/K excretion ratio (67). The effect of aldo-
sterone, the most potent mineralocorticoid, appears to be mediated through . 
RNA and protein synthesis (110, 112). The author is unaware of any report 
on the effects of deoxycorticosterone, corticosterone and cortisol on pre-
cursor incorporation in the kidneys of adrenalectomized rats. . 
The effects of deoxycorticosterone, corticosterone, and cortisol on 
the incorporation of 14c-orotic acid into adrenalectomized rats are shown 
in Tables Xti and XIII. Deoxycorticosterone and corticosterone did not 
modify precursor incorporation into the alkaline hydrolyzate fraction for 
at least two hours following the hormone injection. However, these 
hormones do increase the precursor incorporation into acid soluble pool. 
These findings suggest that aldosterone has a specific effect in increasing 
precursor incor.poration whereas deoxycorticosterone and corticosterone did 
not show any significant effect on the incorporation of precursor into the 
alkaline hydrolyzate fraction of adrenalectomized rat kidneys. 
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14 On the other hand, cortisol decreases the incorporation of C-orotic 
acid into total and alkaline hydrplyzate fraction (Table XIII). No change 
was observed in the acid soluble pool fraction. These studies suggest 
that cortisol may decrease RNA synthesis in rat kidneys. It is of interest 
because cortisol has also been shown to decrease RNA and protein synthesis 
in rat thymus and ··spleen whereas at the same time it increases RNA and 
protein synthesis in rat liver (141). This furnishes another striking 
example of how a steroid hormone can modify RNA synthesis in different 
tissues of the same animal in opposite directions. 
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